Overview

Parecoxib for Treatment of Catheter Related Bladder Discomfort

Status:
Completed

Trial end date:
2016-06-01

Target enrollment:
0

Participant gender:
All

Summary

Catheter-related bladder discomfort (CRBD) is defined as an urge to void or discomfort in the supra-pubic region; reported postoperatively in patients who have had urinary catheterization intra-operatively. In the present study, the investigators evaluated Parecoxib (P) for preventing CRBD in patients undergoing catheterization after transurethral resection of bladder tumor (TURBT).

Phase:

Phase 4

Accepts Healthy Volunteers?

Details

Lead Sponsor:

University Tunis El Manar

Treatments:

Parecoxib

Criteria

Inclusion Criteria:

1. Adult (>/=18)

2. Male or female

3. Undergoing catheterization after transurethral resection of bladder tumor (TURBT)

4. Under spinal anesthesia

5. Subject is American Society of Anesthesiologists (ASA) physical status 1 or 2.

Exclusion Criteria:

1. Patient who disagrees to participate this investigation

2. Patient with severe cardiovascular disease

3. Patient with small-sized foley catheter (less than 18 Fr.)

4. Patinets with bladder outflow obstruction

5. Patient with overactive bladder (frequency >3 times,in the night or >8 times in 24 h)

6. Patients with chronic renal failure

7. Patient with morbid obesity

8. Patient with medications for chronic pain

9. Patient with disturbance of the central nervous system